Spirovant Sciences gets potentially lucrative designation from the FDA
September 29, 2020 at 13:13 PM EDT
The rare pediatric disease designation carries with it a potential big payday for Spirovant.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|